ALBERTDAVD Stock Overview
Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Albert David Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,152.70 |
52 Week High | ₹1,607.90 |
52 Week Low | ₹558.20 |
Beta | 0.33 |
1 Month Change | -2.83% |
3 Month Change | -13.94% |
1 Year Change | 103.12% |
3 Year Change | 135.53% |
5 Year Change | 134.98% |
Change since IPO | 269.16% |
Recent News & Updates
Recent updates
We Think That There Are Issues Underlying Albert David's (NSE:ALBERTDAVD) Earnings
May 21Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price Slump
Mar 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do More
Jan 20Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00
Jul 04Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00
May 22Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching
Feb 14We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now
Sep 08Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Feb 06Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?
Jan 22Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters
Jan 07Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?
Dec 23Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative
Dec 08Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)
Nov 23A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Nov 08Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Oct 13Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?
Sep 28What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?
Sep 13Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?
Aug 28Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?
Aug 10A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)
Aug 10Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks
Jul 20Shareholder Returns
ALBERTDAVD | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -1.9% | 1.9% | 2.9% |
1Y | 103.1% | 62.5% | 45.3% |
Return vs Industry: ALBERTDAVD exceeded the Indian Pharmaceuticals industry which returned 63% over the past year.
Return vs Market: ALBERTDAVD exceeded the Indian Market which returned 44.6% over the past year.
Price Volatility
ALBERTDAVD volatility | |
---|---|
ALBERTDAVD Average Weekly Movement | 6.1% |
Pharmaceuticals Industry Average Movement | 5.7% |
Market Average Movement | 6.5% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ALBERTDAVD has not had significant price volatility in the past 3 months.
Volatility Over Time: ALBERTDAVD's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1938 | 1,271 | Umesh Kunte | www.albertdavidindia.com |
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries.
Albert David Limited Fundamentals Summary
ALBERTDAVD fundamental statistics | |
---|---|
Market cap | ₹6.58b |
Earnings (TTM) | ₹754.20m |
Revenue (TTM) | ₹4.20b |
8.7x
P/E Ratio1.6x
P/S RatioIs ALBERTDAVD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALBERTDAVD income statement (TTM) | |
---|---|
Revenue | ₹4.20b |
Cost of Revenue | ₹1.26b |
Gross Profit | ₹2.94b |
Other Expenses | ₹2.18b |
Earnings | ₹754.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 132.15 |
Gross Margin | 69.91% |
Net Profit Margin | 17.96% |
Debt/Equity Ratio | 0.5% |
How did ALBERTDAVD perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield14%
Payout RatioDoes ALBERTDAVD pay a reliable dividends?
See ALBERTDAVD dividend history and benchmarksAlbert David dividend dates | |
---|---|
Ex Dividend Date | Aug 02 2024 |
Dividend Pay Date | Sep 08 2024 |
Days until Ex dividend | 71 days |
Days until Dividend pay date | 108 days |
Does ALBERTDAVD pay a reliable dividends?
See ALBERTDAVD dividend history and benchmarks